You have 9 free searches left this month | for more free features.

TIM3

Showing 1 - 25 of 746

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Hepatocellular Carcinoma Trial in Beijing (Autologous RAK cells)

Recruiting
  • Hepatocellular Carcinoma
  • Autologous RAK cells
  • Beijing, Beijing, China
    Beijing Hospital Center of Biotherapy
Feb 13, 2023

Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

Active, not recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
Nov 22, 2022

Advanced Solid Tumor Trial (NB002)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jun 29, 2023

Pre-Eclampsia Trial (real time PCR)

Not yet recruiting
  • Pre-Eclampsia
  • real time PCR
  • (no location specified)
Mar 22, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System

Completed
  • Lymphoma, B-Cell
    • Montpellier, France
      Uh Montpellier
    Nov 12, 2021

    Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym023)

    Completed
    • Metastatic Cancer
    • +2 more
    • Grand Rapids, Michigan
    • +3 more
    Oct 11, 2021

    Solid Tumor, Lymphoma Trial (LB1410)

    Recruiting
    • Solid Tumor
    • Lymphoma
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Dec 27, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Dostarlimab (TSR-042) (singly)
    • Dostarlimab (TSR-042) and TSR-022 (combination)
    • Washington, District of Columbia
    • +2 more
    Feb 22, 2022

    Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

    Recruiting
    • Adult Primary Liver Cancer
    • +2 more
    • TSR-022 and TSR-042
    • Honolulu, Hawaii
      University of Hawaii
    Sep 22, 2021

    Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)

    Active, not recruiting
    • Metastatic Cancer
    • Solid Tumor
    • Aurora, Colorado
    • +17 more
    Sep 8, 2022

    NSCLC Trial in Worldwide (AZD7789)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Atlanta, Georgia
    • +8 more
    Jan 12, 2023

    MDS Trial in Boston (MBG453)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
    • +2 more
    Mar 28, 2021

    Solid Tumor Trial in Worldwide (LY3321367, LY3300054)

    Active, not recruiting
    • Solid Tumor
    • Tucson, Arizona
    • +14 more
    Sep 2, 2021

    Advanced or Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (RO7121661, RO7247669, Nivolumab)

    Recruiting
    • Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    • Buenos Aires, Argentina
    • +79 more
    Aug 3, 2022

    Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

    Recruiting
    • Neoplasms
    • Goodyear, Arizona
    • +71 more
    Dec 9, 2022

    Head Neck Cancer Trial (Retifanlimab, INCAGN02385, INCAGN02390)

    Recruiting
    • Head and Neck Cancer
    • Scottsdale, Arizona
    • +87 more
    Dec 12, 2022

    The Status of Immune Checkpoints at Gastrointestinal Cancer

    Completed
    • Gastrointestinal Cancer
    • Flow cytometric analysis
    • Istanbul, Turkey
      Istanbul Training and Reseach Hospital
    Dec 4, 2022

    Immune Checkpoints in Intraabdominal Ascites Fluid

    Completed
    • Colorectal Cancer
    • Flow-cytometric analysis
    • Istanbul, Turkey
      Ufuk Oguz Idiz
    Dec 4, 2022

    Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)

    Terminated
    • Metastatic Melanoma
    • Tumor Infiltrating Lymphocytes
    • Nivolumab and Ipilimumab
    • New Haven, Connecticut
      Yale New Haven Hospital
    Jul 20, 2022

    Advanced Solid Tumor Trial in China (TQB2618 injection and TQB2450 injection)

    Recruiting
    • Advanced Solid Tumor
    • TQB2618 injection and TQB2450 injection
    • Fuzhou, Fujian, China
    • +4 more
    Dec 1, 2022

    MRI Assessment of Leukemia Response to Therapy

    Completed
    • Acute Myelogenous Leukemia
    • 3 Tesla (3T) Siemens Total imaging matrix (TIM) Trio whole-body system
    • Portland, Oregon
      Oregon Health and Science University
    Jul 27, 2019

    Autoimmune Diseases, Multiple Sclerosis Trial in Amman (LPX-TI641)

    Not yet recruiting
    • Autoimmune Diseases
    • Multiple Sclerosis
    • Amman, Jordan
      Triumpharma
    May 11, 2023